Summary
Levels of radioactivity and total anthracycline fluorescence in tissues of A/JAX mice were compared 1 h after IV administration of unlabeled or [14C]-labeled AD 32 (50 mg/kg). Highest levels of both fluorescence and radioactivity were found in the small intestine (including contents) and liver, a result consistent with the known hepatobiliary excretion of AD 32 and metabolites. Significant accumulations of radioactivity and fluorescence were found in kidney, spleen, large intestine (including contents), lung, and heart. Lesser levels were found in muscle and fat. Little radioactivity and fluorescence were found in brain. Liquid chromatographic analysis of extracts of small intestine and liver homogenates showed N-trifluoroacetyladriamycin (AD 41) as the major fluorescent species, and also revealed N-trifluoroacetyladriamycinol (AD 92) and occasional low levels of AD 32. In addition, there was a major peak of nonfluorescent radioactive material and two fluorescent nonradioactive signals (unknowns 1 and 2), indicative of cleavage of the radiolabel from the chromophore.
Similar content being viewed by others
Abbreviations
- AD 32:
-
N-trifluoroacetyladriamycin-14-valerate
- AD 41:
-
N-trifluoroacetyladriamycin
- AD 92:
-
N-trifluoroacetyladriamycinol
- ADR:
-
adriamycin
- AD 48:
-
adriamycin-14-valerate
- AD 60:
-
13-dihydro-N-trifluoroacetyladriamycin-14-valerate
- AMNOL:
-
adriamycinol
- HPLC:
-
high-performance liquid chromatography
- TLC:
-
thin layer chromatography
- SDS:
-
sodium dodecylsulfate
References
Blum RH, Garnick MB, Israel M, Canellos GP, Henderson IC, Frei E III (1979) An initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD 32), an adriamycin analog. Cancer Treat Rep 63: 919
Garnick MB, Israel M, Pegg WJ, Blum RH, Smith E, Frei E III (1979) Hepatobiliary pharmacokinetics of AD 32 in man. Proc Am Assoc Cancer Res/ASCO 20: 206
Henderson IC, Billingham M, Israel M, Krishan A, Frei E III (1978) Comparative cardiotoxicity studies with adriamycin (ADR) and AD 32 in rabbits. Proc Am Assoc Cancer Res/ASCO 19: 158
Israel M, Modest EJ (1977) N-Trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same. U.S. Patent No. 4,035,566, July 12
Israel M, Modest EJ, Frei E III (1975) N-Trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin. Cancer Res 35: 1365
Israel M, Pegg WJ, Seshadri R, Parker LM (1976) N-Trifluoroacetyladriamycin-14-valerate (AD 32): Some in vivo structure-activity relationships. Abstracts, Fifth International Symposium on Medicinal Chemistry, Paris, France, July, p 63
Israel M, Pegg WJ, Wilkinson PM (1978a) Urinary anthracycline metabolites from mice treated with adriamycin and N-trifluoroacetyladriamycin-14-valerate. J Pharmacol Exp Ther 204: 696
Israel M, Wilkinson PM, Pegg WJ, Frei E III (1978b) Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat. Cancer Res 38: 365
Israel M, Karkowsky AM, Pegg WJ (1980a) Pharmacologic studies with radiolabeled N-trifluoroacetyladriamycin-14-valerate (AD 32): Comparison of total anthracycline fluorescence and ratioactivity in mouse serum and urine. Cancer Chemother Pharmacol 4: 79
Israel M, Wilkinson PM, Osteen RT (1980b) Pharmacology studies with adriamycin and N-trifluoroacetyladriamycin-14-valerate (AD 32) in cynomolgus monkeys: Additional evidence for the abscence of an adriamycin-prodrug mechanism for AD 32. In: Crooke ST, Reich SD (eds) Anthracyclines: Current status and new developments. Academic Press, New York, pp 431–444
Israel M, Garnick MB, Pegg WJ, Blum RH, Frei E III (1978) Preliminary pharmacology of AD 32 in man. Proc Am Assoc Cancer Res/ASCO 19: 160
Parker LM, Hirst M, Israel M (1978) N-Trifluoroacetyladriamycin-14-valerate: Additional mouse antitumor and toxicity studies. Cancer Treat Rep 62: 119
Vecchi A, Cairo M, Mantovani A, Sironi M, Spreafico F (1978) Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate. Cancer Treat Rep 62: 111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Israel, M., Karkowsky, A.M. & Khetarpal, V.K. Distribution of radioactivity and anthracycline-fluorescence in tissues of mice one hour after [14C]-labeled AD 32 administration. Cancer Chemother. Pharmacol. 6, 25–30 (1981). https://doi.org/10.1007/BF00253006
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00253006